Skip to main content
SpringerLink
Log in

A pilot program enabling patients/consumers to directly report suspected ADRs in Japan

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. PDMA - Pharmaceuticals and Medical Devices Agency.Launch of the pilot program of “Direct Patient Reporting System for Adverse Drug Reactions“. Pharmaceuticals and Medical Devices Safety Information: 5-7, No. 292, 1 Jul 2012. Available from: URL: http://www.pmda.go.jp

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

A pilot program enabling patients/consumers to directly report suspected ADRs in Japan. React. Wkly. 1418, 3 (2012). https://doi.org/10.2165/00128415-201214180-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214180-00008

Keywords

Search

Navigation